Precision Medicine — Flashcards

#1

What are the approved biomarkers for diagnosing renal AKI?_____

#2

NPM1 and CEBPA mutation is associated with a _____ prognosis in patients with acute myeloid leukemia (AML).

#3

Proteasomal inhibitors are used to treat _____ and mantle cell lymphoma

#4

Besides being indicated for all solid tumors bearing a PD-L1 mutation, Pembrolizumab is indicated for _____ Lymphoma and Colorectal Cancer due to Lynch Syndrome

#5

Discriminant function (DF), also known as _____ score is calculated using prothrombin time and bilirubin level

Want unlimited flashcards?

Get full access to all flashcards, spaced repetition, and progress tracking.

Start For Free
Precision Medicine Flashcards | Medical Innovations and Future Trends Study Cards - OnCourse